- Home
- RPRX vs AR Comparison
RPRX vs AR Comparison
Compare RPRX & AR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- AR
- Stock Information
- Founded
- RPRX 1996
- AR 2002
- Country
- RPRX United States
- AR United States
- Employees
- RPRX N/A
- AR N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- AR Oil & Gas Production
- Sector
- RPRX Health Care
- AR Energy
- Exchange
- RPRX Nasdaq
- AR Nasdaq
- Market Cap
- RPRX 14.0B
- AR 11.6B
- IPO Year
- RPRX 2020
- AR 2013
- Fundamental
- Price
- RPRX $33.88
- AR $37.21
- Analyst Decision
- RPRX Strong Buy
- AR Buy
- Analyst Count
- RPRX 5
- AR 18
- Target Price
- RPRX $41.60
- AR $38.71
- AVG Volume (30 Days)
- RPRX 4.6M
- AR 4.5M
- Earning Date
- RPRX 02-11-2025
- AR 02-12-2025
- Dividend Yield
- RPRX 2.60%
- AR N/A
- EPS Growth
- RPRX N/A
- AR N/A
- EPS
- RPRX 1.91
- AR 0.18
- Revenue
- RPRX $2,263,576,000.00
- AR $4,297,764,000.00
- Revenue This Year
- RPRX $29.18
- AR $29.88
- Revenue Next Year
- RPRX $9.99
- AR $5.14
- P/E Ratio
- RPRX $17.69
- AR $207.67
- Revenue Growth
- RPRX N/A
- AR N/A
- 52 Week Low
- RPRX $24.05
- AR $24.53
- 52 Week High
- RPRX $34.16
- AR $41.53
- Technical
- Relative Strength Index (RSI)
- RPRX 80.55
- AR 43.77
- Support Level
- RPRX $32.28
- AR $38.77
- Resistance Level
- RPRX $34.20
- AR $41.18
- Average True Range (ATR)
- RPRX 0.71
- AR 1.31
- MACD
- RPRX 0.02
- AR -0.38
- Stochastic Oscillator
- RPRX 89.40
- AR 1.59
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About AR Antero Resources Corporation
Antero Resources, based in Denver, engages in the exploration for and production of natural gas and natural gas liquids in the United States and Canada. At the end of 2023, the company reported proven reserves of 18.1 trillion cubic feet of natural gas equivalent. Production averaged approximately 3,483 million cubic feet of equivalent a day in 2023 at a ratio of 37% liquids and 63% natural gas.